Oppenheimer Asset Management’s Organon & Co OGN Stock Holding History

Oppenheimer Asset Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,040	Closed	-$225K	–	1173
2022 Q4	$225K	Sell	8,040 -599	-7%	-$15.3K	﹤0.01%	1042
2022 Q3	$201K	Sell	8,639 -170,300	-95%	-$5.14M	﹤0.01%	1052
2022 Q2	$6.04M	Sell	178,939 -3,278	-2%	-$115K	0.1%	227
2022 Q1	$6.36M	Buy	182,217 +16,066	+10%	+$549K	0.09%	248
2021 Q4	$5.06M	Sell	166,151 -20,299	-11%	-$661K	0.07%	310
2021 Q3	$6.11M	Buy	186,450 +120,650	+183%	+$3.86M	0.09%	269
2021 Q2	$1.99M	Buy	+65,800	New	+$2.17M	0.03%	542

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer Asset Management's OGN Position: Q1 2023 in Review

Oppenheimer Asset Management sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 8,040 shares — an estimated $225K sold.

Oppenheimer Asset Management first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $6.36M in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

Oppenheimer Asset Management reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
Oppenheimer Asset Management sold 8,040 Organon & Co shares in Q1 2023, an estimated $225K.
Oppenheimer Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
Oppenheimer Asset Management's Organon & Co position peaked at $6.36M in Q1 2022.
767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Oppenheimer Asset Management's 13F filing for Q1 2023, filed 10 May 2023.